Maze Therapeutics CSBO Atul Dandekar reports sale of common shares worth $240,531.75
MAZE•Maze Therapeutics CSBO Atul Dandekar sold 7,500 common shares for a weighted-average $32.0709 each and exercised options for 7,500 shares at $10.42 each. He directly owned 32,316 shares after the transactions.
1. Share transactions
Atul Dandekar, chief strategy and business officer of Maze Therapeutics, sold 7,500 common shares on October 29, 2026, at a weighted-average price of $32.0709. He also exercised stock options for 7,500 common shares at $10.42 per share, bringing his direct beneficial ownership to 32,316 shares.
